Literature DB >> 18218703

Receptor-mediated delivery of siRNAs by tethered nucleic acid base-paired interactions.

Kexiong Zhang1, Qiaoqiao Wang, Yanhua Xie, Gil Mor, Emanuela Sega, Philip S Low, Yingqun Huang.   

Abstract

We report a new strategy for cell-type-specific delivery of functional siRNAs into cells. The method involves the noncovalent attachment of siRNAs to ligand-conjugated oligodeoxynucleotides via nucleic acid base-paired interactions. The resulting complexes can be directly applied to cells, leading to specific cellular uptake and gene silencing. The method is simple, economical, and can be easily adapted for other cell surface receptors. Here we show the application of this method for the delivery of siRNAs to folate receptor-expressing cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18218703      PMCID: PMC2248269          DOI: 10.1261/rna.739308

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  19 in total

1.  Sequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewing's sarcoma.

Authors:  Siwen Hu-Lieskovan; Jeremy D Heidel; Derek W Bartlett; Mark E Davis; Timothy J Triche
Journal:  Cancer Res       Date:  2005-10-01       Impact factor: 12.701

2.  Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras.

Authors:  James O McNamara; Eran R Andrechek; Yong Wang; Kristi D Viles; Rachel E Rempel; Eli Gilboa; Bruce A Sullenger; Paloma H Giangrande
Journal:  Nat Biotechnol       Date:  2006-06-25       Impact factor: 54.908

3.  Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors.

Authors:  Erwei Song; Pengcheng Zhu; Sang-Kyung Lee; Dipanjan Chowdhury; Steven Kussman; Derek M Dykxhoorn; Yi Feng; Deborah Palliser; David B Weiner; Premlata Shankar; Wayne A Marasco; Judy Lieberman
Journal:  Nat Biotechnol       Date:  2005-05-22       Impact factor: 54.908

4.  Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay.

Authors:  Nikki Parker; Mary Jo Turk; Elaine Westrick; Jeffrey D Lewis; Philip S Low; Christopher P Leamon
Journal:  Anal Biochem       Date:  2005-03-15       Impact factor: 3.365

5.  Folate-conjugated liposomes preferentially target macrophages associated with ovarian carcinoma.

Authors:  Mary Jo Turk; David J Waters; Philip S Low
Journal:  Cancer Lett       Date:  2004-09-30       Impact factor: 8.679

6.  Construction of folate-conjugated pRNA of bacteriophage phi29 DNA packaging motor for delivery of chimeric siRNA to nasopharyngeal carcinoma cells.

Authors:  S Guo; F Huang; P Guo
Journal:  Gene Ther       Date:  2006-05       Impact factor: 5.250

7.  Activation of the interferon system by short-interfering RNAs.

Authors:  Carol A Sledz; Michelle Holko; Michael J de Veer; Robert H Silverman; Bryan R G Williams
Journal:  Nat Cell Biol       Date:  2003-08-24       Impact factor: 28.824

8.  Folate-targeted PEG as a potential carrier for carboplatin analogs. Synthesis and in vitro studies.

Authors:  Olga Aronov; Aviva T Horowitz; Alberto Gabizon; Dan Gibson
Journal:  Bioconjug Chem       Date:  2003 May-Jun       Impact factor: 4.774

9.  Small interfering RNAs mediate sequence-independent gene suppression and induce immune activation by signaling through toll-like receptor 3.

Authors:  Katalin Karikó; Prakash Bhuyan; John Capodici; Drew Weissman
Journal:  J Immunol       Date:  2004-06-01       Impact factor: 5.422

10.  Arg-Gly-Asp peptide increases endothelial hydraulic conductivity: comparison with thrombin response.

Authors:  R L Qiao; W Yan; H Lum; A B Malik
Journal:  Am J Physiol       Date:  1995-07
View more
  10 in total

Review 1.  Targeted delivery systems for oligonucleotide therapeutics.

Authors:  Bo Yu; Xiaobin Zhao; L James Lee; Robert J Lee
Journal:  AAPS J       Date:  2009-03-19       Impact factor: 4.009

Review 2.  Engineering RNA for targeted siRNA delivery and medical application.

Authors:  Peixuan Guo; Oana Coban; Nicholas M Snead; Joe Trebley; Steve Hoeprich; Songchuan Guo; Yi Shu
Journal:  Adv Drug Deliv Rev       Date:  2010-03-15       Impact factor: 15.470

3.  Evaluation of specific delivery of chimeric phi29 pRNA/siRNA nanoparticles to multiple tumor cells.

Authors:  Li Li; Jing Liu; Zhijuan Diao; Dan Shu; Peixuan Guo; Guanxin Shen
Journal:  Mol Biosyst       Date:  2009-07-27

4.  Site-specific antibody-polymer conjugates for siRNA delivery.

Authors:  Hua Lu; Danling Wang; Stephanie Kazane; Tsotne Javahishvili; Feng Tian; Frank Song; Aaron Sellers; Barney Barnett; Peter G Schultz
Journal:  J Am Chem Soc       Date:  2013-09-05       Impact factor: 15.419

5.  Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance.

Authors:  Ayesha B Alvero; Rui Chen; Han-Hsuan Fu; Michele Montagna; Peter E Schwartz; Thomas Rutherford; Dan-Arin Silasi; Karina D Steffensen; Marianne Waldstrom; Irene Visintin; Gil Mor
Journal:  Cell Cycle       Date:  2009-01-01       Impact factor: 4.534

6.  FolamiRs: Ligand-targeted, vehicle-free delivery of microRNAs for the treatment of cancer.

Authors:  Esteban A Orellana; Srinivasarao Tenneti; Loganathan Rangasamy; L Tiffany Lyle; Philip S Low; Andrea L Kasinski
Journal:  Sci Transl Med       Date:  2017-08-02       Impact factor: 17.956

7.  Vasopressin V2R-targeting peptide carrier mediates siRNA delivery into collecting duct cells.

Authors:  Hyun Jun Jung; Jung-Suk Lim; Hyo-Jung Choi; Mi Suk Lee; Jong-Ho Kim; Sang-Yeob Kim; Soyoun Kim; Eunjung Kim; Tae-Hwan Kwon
Journal:  PLoS One       Date:  2012-06-28       Impact factor: 3.240

8.  Ligand-mediated delivery of RNAi-based therapeutics for the treatment of oncological diseases.

Authors:  Ahmed M Abdelaal; Andrea L Kasinski
Journal:  NAR Cancer       Date:  2021-07-20

9.  New type of BACE1 siRNA delivery to cells.

Authors:  Maciej Jabłkowski; Maciej Szemraj; Katarzyna Oszajca; Grażyna Janiszewska; Jacek Bartkowiak; Janusz Szemraj
Journal:  Med Sci Monit       Date:  2014-12-10

Review 10.  RNA interference: from basic research to therapeutic applications.

Authors:  Jens Kurreck
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.